BioSpring GmbH

Divi’s Laboratories Limited (Divi’s), is a pharmaceutical company headquartered in Hyderabad, India.
Divi’s is engaged in manufacturing leading generic compounds, nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies primarily for export to regulated markets such as US and Europe. With two manufacturing facilities, market presence across several countries and a team of 10,000 employees, Divi’s continues to innovate to bring robust techniques to facilitating sustainable manufacturing processes.

The company was founded in 1990 by Dr. Murali K Divi with research and development as its core area. Started initially as a Research and Development Center, it expanded and focused on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates, providing complete turnkey solutions and consulting to the domestic pharmaceutical industry.

Symphony was founded by eminent experts from Pharma Industry to create new bench mark in collaborative Research and Services.

Symphony provides Chemistry Services for:

 Chemistry support for early stage drug discovery molecules, building blocks & scaffolds, analogues & library compounds synthesis
 cGMP Kilo scale manufacturing & supply (up to 25Kg) of clinical drug substance (NCE) for preclinical to clinical studies
 CMC documentation & support for NDA submission
 Experience of working on more than 40 NCEs for our Global Innovator clients on FTE (Full Time Equivalent) & FFS (Fee For Service) client engagement models.
 Custom Synthesis from mg to kg for non-catalogue/expensive catalogue compounds
 Non-infringing and cost effective process development for generic APIs and intermediates and technical package submissions for commercial manufacturing
 Process validations under cGMP pilot plant
 Analytical (HPLC/GC) method development & validations


Symphony has expert team of Scientists and marketing professionals with an excellent track record of Research and timely delivery capabilities.

AcceleDev is a small molecule development & production company, with a staff of 100 people. Global operations include R&D & manufacturing sites in USA & China. Business specialties in the areas of "custom synthesis of advances intermediates"​ & "qualification/supply of raw materials"​, primarily in support of Pharmaceutical API programs.

Welcome to Angene
Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, intermediates, bulk commodities, agro-chemicals, natural ingredients and active pharmaceutical ingredients (APIs). In addition to the 100,000+ products, Angene offers custom synthesis of chemicals that are not commercially available.

Please contact us for quotation at sales@angenechemical.com.

API MANUFACTURING:
Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk (Schedule II–V) controlled actives, however non-controlled APIs are also within our project portfolio.

ANALYTICAL SERVICES:
Apertus performs analytical methods development and services on a variety of instrument platforms. Our primary focus is LC (UV), LCMS and GCMS. We can use existing methods or develop novel methods on a per-project basis. In addition, we can provide methods validation, impurity identification and tech transfer packages.

PHARMACEUTICAL SERVICES:
Apertus provides services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. In addition we can aid in characterizing RLDs via dissolution profiles, chemical analysis and microscopy. All services can be provided under cGMP if desired.